Home Newsfeeds Janney Montgomery Scott Downgrades Salisbury Bancorp to Neutral

Janney Montgomery Scott Downgrades Salisbury Bancorp to Neutral

Janney Montgomery Scott analyst Jake Civiello downgrades Salisbury Bancorp (NASDAQ:SAL) from Buy to Neutral.

byBenzinga Newsdesk

December 6, 2022

1 minute read

Janney Montgomery Scott analyst Jake Civiello downgrades Salisbury Bancorp (NASDAQ:SAL) from Buy to Neutral.

Vertex Bags US Navy Contract Worth ~$230M

By Akanksha Bakshi

August 30, 1:28 PM

Vertex, a V2X, Inc. (NYSE:VVX) company, has secured a contract valued at up to $230 million for contractor logistics support for the…

VVX

NGM Biopharmaceuticals Q4 EPS $(0.45) Beats $(0.51) Estimate, Sales $18.18M Beat $6.76M Estimate

By Bill Haddad

February 28, 5:56 PM

NGM Biopharmaceuticals (NASDAQ:NGM) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.51) by 11.76 percent. This is a 28.57 percent decrease over losses of $(0.35) per share

NGM

Reported Late Tuesday Feb. 28, Regeneron Pharmaceuticals And Sanofi Announce Kevzara Approved By FDA As First And Only Biologic Indicated For Patients With Polymyalgia Rheumatica

By Happy Mohamed

March 1, 1:25 AM

Three times more patients treated with Kevzara achieved sustained remission compared to placebo in Phase 3 trial Kevzara now approved to treat two chronic inflammatory disorders TARRYTOWN, N.Y. and CAMBRIDGE,

REGN

Medterra Launches Hemp-Infused CBD Products On Amazon, Check Out These Special Offers

By Jelena Martinovic

October 6, 10:55 AM

Hemp-derived CBD products maker Medterra announced on Friday that it is officially launching on Amazon (NASDAQ: AMZN), one of the world's largest online marketplaces.

AMZN

Janney Montgomery Scott Downgrades Salisbury Bancorp to Neutral

Related Posts

Vertex Bags US Navy Contract Worth ~$230M

NGM Biopharmaceuticals Q4 EPS $(0.45) Beats $(0.51) Estimate, Sales $18.18M Beat $6.76M Estimate

Reported Late Tuesday Feb. 28, Regeneron Pharmaceuticals And Sanofi Announce Kevzara Approved By FDA As First And Only Biologic Indicated For Patients With Polymyalgia Rheumatica

Medterra Launches Hemp-Infused CBD Products On Amazon, Check Out These Special Offers